Abstract
During the last decade evidence-based medicine (EBM) has become a dominant approach in many medical fields, including ophthalmology. Clinical epidemiological studies provide evidence that can aid the decision-making processes. An overwhelming amount of clinical epidemiological papers are being published every year, and critical appraisal of the findings can be challenging, especially for the busy clinician who is not formally trained in the field of clinical epidemiology. Therefore the available evidence is increasingly bundled in clinical guidelines. The aim of this chapter is to provide the readers with some basic knowledge to allow them to judge the value of clinical epidemiological papers and thus of the pillars of evidence-based clinical guidelines. Examples from ocular oncology will be used to illustrate the methodological principles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sackett DL. Clinical epidemiology. What, who, and whither. J Clin Epidemiol. 2002;55:1161–6.
Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users’ Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users’ Guides to patient care. Evidence-Based Medicine Working Group. JAMA. 2000;284:1290–6.
Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. 2003;361:309–10.
Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195–8.
Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994. Int J Cancer. 1996;67:515–9.
Shakin EP, Shields JA, Shields CL. Metastatic cancer to the uvea: a survey of 300 cases. In: Shields JA, Shields CL, editors. Intraocular tumors: a text and atlas. Philadelphia: Saunders; 1992. p. 235.
Foss AJ, Lamping DL, Schroter S, et al. Development and validation of a patient based measure of outcome in ocular melanoma. Br J Ophthalmol. 2000;84:347–51.
Moll AC, Imhof SM, Kuik DJ, et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862–1994. Hum Genet. 1996;98:109–12.
Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96:357–63.
Moll AC, Imhof SM, Schouten-van Meeteren AYN, et al. Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol. 2001;120:1774.
Stang A, Ahrens W, Baumgardt-Elms C, et al. Cooking and uveal melanoma risk: results from two German case-control studies. Cancer Causes Control. 2003;14:377–80.
Harbour JW. What is the best treatment for retinoblastoma? Am J Ophthalmol. 2004;138:471–3.
Harbour JW, Brantley Jr MA, Hollingsworth H, et al. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol. 2004;88:39–43.
Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol. 1999;52:487–97.
Oxman AD, Guyatt GH. A consumer’s guide to subgroup analyses. Ann Intern Med. 1992;116:78–84.
Lasky T, Stolley PD. Selection of cases and controls. Epidemiol Rev. 1994;16:6–17.
Friedman LM, Furberg CD, De Mets DL. Fundamentals of clinical trials. St Louis: Mosby; 1996.
Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand. 1999;77:414–7.
Liu DK, Yao B, Fayz B, Womble DD, Krawetz SA. Comparative evaluation of microarray analysis software. Mol Biotechnol. 2004;26(3):225–32.
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.
Zhang Y, Szustakowski J, Schinke M. Bioinformatics analysis of microarray data. Methods Mol Biol. 2009;573:259–84.
Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34(2):374–8.
Glaab E, Garibaldi JM, Krasnogor N. ArrayMining: a modular web-application for microarray analysis combining ensemble and consensus methods with cross-study normalization. BMC Bioinformatics. 2009;10:358. doi:10.1186/1471-2105-10-358.
Xia X, McClelland M, Wang Y. WebArray: an online platform for microarray data analysis. BMC Bioinformatics. 2005;6:306.
Suarez E, Burguete A, Mclachlan GJ. Microarray data analysis for differential expression: a tutorial. P R Health Sci J. 2009;28(2):89–104.
Yang IV, Chen E, Hasseman JP, Liang W, Frank BC, Wang S, et al. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol. 2002;3(11):research0062.
Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30(4):e15.
Quackenbush J. Microarray data normalization and transformation. Nat Genet. 2002;32(Suppl):496–501.
Schadt EE, Li C, Ellis B, Wong WH. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem. 2001;Suppl 37:120–5.
Quackenbush J. Microarray analysis and tumor classification. N Engl J Med. 2006;354(23):2463–72.
Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85–97.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.
Further Reading
Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. Baltimore: Williams & Wilkins; 1996.
Guyatt G, Rennie D, editors. Users’ guide to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press; 2002.
Microarrays: Chipping away at the mysteries of science and medicine. http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html.
Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. Edinburgh: Churchill Livingstone; 2000.
User’s guide to evidence-based practice. Educative series of articles from the JAMA. www.cche.net/usersguides/main.asp.
Website of the centre for evidence-based medicine, Oxford, United Kingdom. www.cebm.net.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Moll, A.C., de Boer, M.R., Bouter, L.M., Singh, N. (2014). Principles of Clinical Epidemiology. In: Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40489-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-40489-4_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40488-7
Online ISBN: 978-3-642-40489-4
eBook Packages: MedicineMedicine (R0)